Figure S2 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells

Soyoung Lee(Institute for Basic Science), Seung Woo Cho(Stanford University), In Ho Song(Asan Medical Center), Hye‐Jin Jeong(Ulsan National Institute of Science and Technology), Yoon Ji Choi(Ulsan National Institute of Science and Technology), Minjong Kim(Ulsan National Institute of Science and Technology), Euihwan Jeong(Io Therapeutics (United States)), Heon Seok Kim(Hanyang University), Tae‐Eun Park(Ulsan National Institute of Science and Technology), Seon‐gyeong Lee(Institute for Basic Science), Kyungjae Myung(Institute for Basic Science), Kayeong Lim(Bio-Medical Science (South Korea)), Himchan Cheng(Ulsan National Institute of Science and Technology), Jinmyoung Joo(Institute for Basic Science), Eun A Lee(Institute for Basic Science), Taejoon Kwon(Ulsan College), Chang Sik Yu(Yonsei University), Deok‐Beom Jung(Ulsan College), Kyunghwan Kim(Institute for Basic Science), Dayoung Kim(Huadong Hospital), Jinhee Mun(Ulsan National Institute of Science and Technology), Seung‐Jae Myung(Ulsan College), Subin Choi(Institute of Cancer Research), Yewon Jang(Institute for Basic Science), Joo H. Kang(Boston Children's Hospital), Soomin Heo(Institute for Basic Science), M. Ryan Corces(Gladstone Institutes)
Unknown
August 1, 2025
Cited by 0


Related Papers